1. Home
  2. VFF vs SKYE Comparison

VFF vs SKYE Comparison

Compare VFF & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VFF
  • SKYE
  • Stock Information
  • Founded
  • VFF 1989
  • SKYE 2012
  • Country
  • VFF Canada
  • SKYE United States
  • Employees
  • VFF N/A
  • SKYE N/A
  • Industry
  • VFF
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VFF
  • SKYE Health Care
  • Exchange
  • VFF Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • VFF 87.5M
  • SKYE 80.7M
  • IPO Year
  • VFF N/A
  • SKYE N/A
  • Fundamental
  • Price
  • VFF $0.60
  • SKYE $1.59
  • Analyst Decision
  • VFF Buy
  • SKYE Buy
  • Analyst Count
  • VFF 1
  • SKYE 7
  • Target Price
  • VFF N/A
  • SKYE $18.00
  • AVG Volume (30 Days)
  • VFF 305.0K
  • SKYE 192.9K
  • Earning Date
  • VFF 03-13-2025
  • SKYE 03-20-2025
  • Dividend Yield
  • VFF N/A
  • SKYE N/A
  • EPS Growth
  • VFF N/A
  • SKYE N/A
  • EPS
  • VFF N/A
  • SKYE N/A
  • Revenue
  • VFF $336,181,000.00
  • SKYE N/A
  • Revenue This Year
  • VFF $2.13
  • SKYE N/A
  • Revenue Next Year
  • VFF $9.93
  • SKYE N/A
  • P/E Ratio
  • VFF N/A
  • SKYE N/A
  • Revenue Growth
  • VFF 17.71
  • SKYE N/A
  • 52 Week Low
  • VFF $0.60
  • SKYE $1.56
  • 52 Week High
  • VFF $1.62
  • SKYE $17.65
  • Technical
  • Relative Strength Index (RSI)
  • VFF 35.85
  • SKYE 30.46
  • Support Level
  • VFF $0.62
  • SKYE $2.08
  • Resistance Level
  • VFF $0.68
  • SKYE $2.44
  • Average True Range (ATR)
  • VFF 0.04
  • SKYE 0.29
  • MACD
  • VFF -0.01
  • SKYE -0.05
  • Stochastic Oscillator
  • VFF 1.54
  • SKYE 2.27

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The Company has identified four operating segments - Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The company makes majority of its revenue from the Produce segment.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: